Methvin Isaac

ISOQUINOLINE DERIVATIVES AS INHIBITORS OF BAX AND/OR BAK, COMPOSITIONS AND USES THEREOF

HALO-SUBSTITUTED AMINO AZA-HETEROARYL COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1)

HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1)

SUBSTITUTED AMINO AZA-HETEROARYL COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1)

ERGOLINE-DERIVED AGONISTS OF THE 5-HT2A RECEPTOR

5-HT2A AND/OR 5-HT2C RECEPTOR AGONISTS

ISOINDOLINONE AMINOPYRIMIDINE COMPOUNDS AS INHIBITORS OF NUAK KINASES, COMPOSITIONS AND USES THEREOF

THIENYL AND CYCLOALKYL AMINOPYRIMIDINE COMPOUNDS AS INHIBITORS OF NUAK KINASES, COMPOSITIONS AND USES THEREOF

Substituted carboxamides as inhibitors of WDR5 protein-protein binding

Tricyclic inhibitors of the BCL6 BTB domain protein-protein interaction and uses thereof

INHIBITORS OF WDR5 PROTEIN-PROTEIN BINDING

Substituted heteroaryls as inhibitors of the BCL6 BTB domain protein-protein interaction

Quinolone compounds as inhibitors of the BCL6 BTB domain protein-protein interaction and/or as BCL6 degraders

Deuterated compounds as inhibitors of the BCL6 BTB domain protein-protein interaction and/or as BCL6 degraders

Substituted carboxamides as inhibitors of WDR5 protein-protein binding

Substituted carboxamides as inhibitors of WDR5 protein-protein binding

USE OF D-SERINE DERIVATIVES FOR THE TREATMENT OF ANXIETY DISORDERS

Substituted Isoindolones and Their Use as Metabotropic Glutamate Receptor Potentiators

AZA-Isoindolones and Their Use as Metabotropic Glutamate Receptor Potentiators - 613

Metabotropic glutamate-receptor-potentiating isoindolones

Metabotropic Glutamate Receptor Oxadiazole Ligands and Their Use as Potentiators

Use of D-serine derivatives for the treatment of anxiety disorders

Bicyclic Benzimidazole Compounds and Their Use as Metabotropic Glutamate Receptor Potentiators

Metabotropic Glutamate Receptor-Potentiating Isoindolones

Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators

Substituted isoindolones and their use as metabotropic glutamate receptor potentiators

AMINO 1,2,4-TRIAZOLE DERIVATIVES AS MODULATORS OF MGLUR5

Pyrazolone Compounds As Metabotropic Glutamate Receptor Agonists For The Treatment Of Neurological And Psychiatric Disorders

Use

Piperazines and piperidines as Mglur5 potentiators

Oxazolidinone Compounds and Their Use as Metabotropic Glutamate Receptor Potentiators

Tricyclic Benzimidazoles and Their Use as Metabotropic Glutamate Receptor Modulators

Substituted Piperazines as Metabotropic Glutamate Receptor Antagonists

Bicyclic Piperazines as Metabotropic Glutatmate Receptor Antagonists

Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators 841

Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators 842

5-(Phenylisoxazolylethoxy) - Triazol- 3 -Yl Substituted Pyridine Compounds for the Treatment of Neurological, Psychiatric or Pain Disorders

Metabotropic glutamate-receptor-potentiating isoindolones

mGluR5 modulators

Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators

ADDITIONAL HETEROPOLYCYCLIC COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS

ADDITIONAL HETEROPOLYCYCLIC COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS

ADDITIONAL HETEROPOLYCYCLIC COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS

ADDITIONAL HETEROPOLYCYCLIC COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS

NEW COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL, PSYCHIATRIC OR PAIN DISORDERS

NEW COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL, PSYCHIATRIC OR PAIN DISORDERS

mGluR5 modulators III

MGluR5 modulators IV

mGluR5 modulators II

MGluR5 modulators VI

MGluR5 modulators I

MGluR5 modulators V

Triazole compounds and their use as metabotropic glutamate receptor antagonists

Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonists

Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists

Substituted piperazines as metabotropic glutamate receptor antagonists

Bicyclic piperazines as metabotropic glutatmate receptor antagonists